Open Forum Infectious Diseases

Article	Citations
83. Infectious Outcomes of CAR T-cell Therapy: Longitudinal Follow Up and Risk Stratification	218
734. Efficacy of sulbactam-durlobactam (SUL-DUR) versus colistin in patients with extensively drug-resistant (XDR) and pan-drug resistant (PDR) Acinetobacter baumannii-calcoaceticus complex (AB	192
822. Is the Juice Worth the Squeeze: Ophthalmologist Examination for All Hospitalized Patients with Candidemia in a Rural Community	146
382. Are errors of omission falsely inflating hospital-onset Clostridioides difficile infection numbers?	128
1404. Remotely Piloted Aircraft & Quadcopters used in Combating Malaria/Dengue in desert terrain	117
2538. The Impact of Rifampicin on Blood Pressure in Patients Receiving Nifedipine: A Retrospective Study	91
2115. Long Term Follow-up and Correlates of Success in Patients on Immune Globulin for Antibody Deficiency	90
328. One-Day Holiday: An Approach to Managing Daptomycin-Induced CK Elevations in OPAT	88
P-721. Risk Factors Associated with COVID-19 Among Fully Vaccinated Healthcare Workers in Lima, Peru	88
2678. Prevalence of gonorrhea, chlamydia and syphilis among males living with HIV attending the Antiretroviral Clinic, Hospital Santo Tomás, Panamá, November 2021-March 2022	87
1753. Impact of a Pharmacist-Driven Home Hospital Antimicrobial Stewardship Program Pilot within a Large Community Health System	87
A Case Report of Melioidotic Prostatic Abscess in a Traveler	86
P-1507. In Vitro Activity of Ceftazidime-avibactam against Enterobacterales Isolates Producing Multiple β-lactamases Collected Globally as a Part of the ATLAS Global Surveillance Program from 2	72
P-1665. Predictors of Antibiotic Prescription for Upper Respiratory Tract Infections in Cancer Patients	71
P-291. Whole genome sequencing (WGS) demonstrates high relatedness between carbapenemase-producing Klebsiella pneumoniae isolates cultured from paired rectal swab and blood specimens among hosp	68
P-662. Phase III, modified double-blind, randomized, parallel group, active-controlled, multi-center study of Meningococcal quadrivalent ACWY conjugated vaccine in infants from 6 through 23 months of	68
839. Insights into Histoplasmosis in India: A Tertiary Care Centre Experience	67
Underdosed and Underappreciated: Why Japanese Community-Acquired Pneumonia Outcomes With Ampicillin-Sulbactam May Not Translate Globally	66
849. Histopathology of Cutaneous Invasive Fungal Infections in a Tertiary Cancer Center: Causes, Discordance with Culture, and Histopathologic Determinants of Outcome	64
1407. Migration Timing and its Association with Disease Features in a Chagas Disease Cohort in New England	62
1957. Increased short-term vaccine effectiveness of BNT162b2 with same-arm vs. cross-arm administration of sequential doses	53
855. Distinguishing between drug-susceptible and resistant Neisseria gonorrhoeae from urine samples by image recognition AI.	50
665. Modified Superposition in vitro Susceptibility of Aztreonam and Ceftazidime/Avibactam for an NDM-5 Metallo-β-Lactamase-Producing Klebsiella pneumoniae Isolate	50
P-1193. Epidemiology of Respiratory Syncytial Virus in Young, Hospitalized Children in Jordan: A Prospective Viral Surveillance Study	49
P-735. Acute Bacterial Skin and Skin Structure Infections: A Comparison of Outpatient One-Hour Infusion Oritavancin and Inpatient Vancomycin Use	49

1706. Risk factors for infections caused by extended spectrum beta lactamase (ESBL) producing and Carbapenem-resistant Enterobacterales (CRE) in pediatric critical care settings: A case control study	48
912. Impact of Rapid Identification and Stewardship Intervention on Coagulase-negative Staphylococcus Bloodstream Infection (BSI)	47
430. Tumor microbiota and tumor-infiltrating T cells in the tumor microenvironment of colorectal cancer	46
P-511. Missed Opportunities for Pre-Exposure Prophylaxis Initiation in Hospitalized Persons with Opioid Use Disorder and Infectious Diseases	46
P-528. Opportunities for PrEP Awareness and Engagement: A Survey among Healthcare-Seeking Cisgender Women in the US	46
P-2156. Impact of Metagenomic Next-Generation Sequencing of Plasma Cell-Free DNA on Infectious Diseases Management in Adult and Pediatric Patients	45
178. Assessment of an IOTA (Intravenous to Oral Transition of Antimicrobial Therapy) in Gram Negative Bacteremias at a Community Teaching Hospital	45
Editor’s Note: Development of a Quantitative Antigen Assay to Detect Coccidioidal Chitinase-1 (CTS1) in Human Serum	43
1349. Unveiling the Link between COVID-19 and the Gut Microbiome in an Outpatient Cohort with Mild to Moderate Illness	43
1827. Patients with Serious Injection Related Infections (SIRI) have Limited Access to Community-based Infection Prevention and Treatment in Alabama	42
829. 5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Sub-study of the EnACT Trial Testing Oral Amphotericin	40
P-1158. Surgical Outcomes Following Paenibacillus Infant Infectious Hydrocephalus	40
1122. Early Infectious Diseases Consultation and Procalcitonin-Guided Therapy Limits Unnecessary Antibiotic Use in COVID-19	39
P-1709. Factors Associated with Anti-Methicillin-Resistant Staphylococcus aureus and Anti-Pseudomonas aeruginosa Therapy in Critically Ill Patients with Community-Acquired Pneumonia: A S	38
Has Ghana's Rotavirus Vaccine Switch Met Programmatic Expectations? An Analysis of National Surveillance Data; 2018–2022	38
Cerebrospinal Fluid Lactate Levels as a Prognostic Indicator in Patients With Cryptococcal Meningitis Who Are HIV Negative: A Retrospective Cohort Study	38
P-803. A 10-year Retrospective Analysis of Staphylococcus aureus Bacteremia in a Philippine Tertiary Hospital	37
P-2095. Ultrasensitive Clostridioides difficile Toxin A/B Assay (in Development) for Higher Diagnostic Accuracy	37
Systemic Mycoses by Novel Onygenalean Fungal Pathogens Emergomyces spp and Blastomyces percursus in Rwanda	36
P-1383. Gap in Doxy PEP Prescription for People Living With HIV Compared with PrEP Users in a Primary Care Practice	35
377. Impact of VE303, a Defined Bacterial Consortium, on Antimicrobial Resistant Gene Prevalence in Patients with Clostridioides difficile Infection (CDI)	35
P-2292. The Usual Suspect? Prevalence of Pseudomonas aeruginosa in Diabetic Foot Infections among Kidney Transplant Recipients	35
P-2184. Antiviral Use among Immigrants with Chronic Hepatitis B (HBV) in Metropolitan-DC	35
380. Implementation of Pooled Saliva Tests for Universal Screening of Congenital Cytomegalovirus (cCMV) Infection: Lessons Derived Over a 25-Months Period	34
P-2295. Risk Factors for and Impact of Enteric Gram-negative Infections on Lung Transplant Clinical Outcomes	34
Disseminated TB With IRIS Presenting as a Pancreatic Mass in Newly Diagnosed HIV: A Case Report	34
1326. Comparison of Positive BioFire® FilmArray® Meningitis Encephalitis (ME) Panels, CSF cultures, CSF Parameters and Inpatient Mortality Among Patients with Bacterial and Fungal Meningitis	33
P-2248. Modeling the Economic Impact of Different Testing Strategies for Meningitis/Encephalitis in Adult Patients from a US Hospital Perspective	33
2289. Accuracy of the National Early Warning Score 2 (NEWS2) in predicting Mortality and ICU Admission among COVID-19 patients in the Emergency Department of a Tertiary Private Hospital in the Philipp	33
P-502. Incorporating Behavioral Economics to Educate Adolescents and Young Adults about HIV Pre-Exposure Prophylaxis	32
P-1844. T cell Subtypes and DNA Methylome Dynamics Predict Infection after Kidney Transplantation	32
P-115. Lessons from Establishing a Vaccine Trial Clinic: Insights from the University of Louisville's Center of Excellence for Research in Infectious Diseases	32
P-1870. Clinical Outcomes of Self-Administered Outpatient Parenteral Antimicrobial Therapy over 12 Years in a Safety Net Hospital	32
P-1451. Missed Opportunities for HIV Diagnosis in Mexico City: Unveiling the Gender Gap	32
P-1459. Racial Disparities in Treatment of Community-Acquired Pneumonia in Hospitalized Patients	32
2327. Masking without Mandates: Patient Preferences	32
P-1523. Evaluation of Standardized Treatment Regimens for Patients with Documented Melioidosis Septicemia at Tertiary Care Hospital in Thailand	31
770. HIV Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) knowledge among Medical Students in the Dominican Republic: Are we missing the role of Future Healthcare Provider in PrEP a	31
645. " Risk of Disease Severity and Disease Outcomes with Serotype-Specific Dengue Virus among Hospitalized Dengue Patients in a Tertiary Infectious Diseases Hospital: A Five-Year Retrospective Study"	31
P-609. Assessment of Parents’ Awareness and Attitudes towards Respiratory Syncytial Virus and its Prevention in the US	31
774. Trivia Game for Learning Zoonotic Diseases in Pre-clinical Medical Curriculum	30
Trimethoprim-Sulfamethoxazole for Staphylococcus Aureus Bacteremia Prophylaxis in Patients on Hemodialysis: A Future Tool for the “Swiss Army Knife” of Antibiotics?	30
P-1607. Comparison of In-House Versus Reference Laboratory Antifungal Susceptibility Testing on De-Escalation Rates of Echinocandin Therapy for Candidemia	30
P-138. Effect of diabetes mellitus on the disease entity and clinical parameters in culture positive melioidosis	30
777. Cytomegalovirus: Curriculum-Based Online Education Improves Knowledge, Competence, and Confidence of Physicians	30
1381. Barriers and Facilitators to Prompt Diagnosis of Tuberculosis in Lima, Peru	30
1404. Factors Associated to Decrease in Quality of Life After Mild-Moderate COVID-19: A Cross-Sectional Study.	29
1430. Eravacycline associated hypofibrinogenemia during treatment of M.abscessus	29
P-193. Risk Factors Associated with Patients Diagnosed with Clostridioides difficile Infection with no Documented Antibiotic Exposures	29
326. Optimizing DNA Extraction from Pediatric Stool for Diagnosing Tuberculosis and Use in Next Generation Sequencing	29

1572. Impact of a Multicenter Fluoroquinolone Stewardship Collaboration on Prescribing Trends over Five Years	28
1244. Inpatient vs. outpatient initiation of Hepatitis C treatment among hospitalized patients who inject drugs: Lessons from a quality improvement project	28
606. Efficacy and Safety of Ceftazidime-Avibactam Comparative Dosage Regimens in Patients with Kidney Injury: A Retrospective Cohort Study	28
509. Role of cell-mediated immune monitoring using Interferon-γ Enzyme-linked Immunosorbent Spot Assay to predict CMV infection within six months after kidney transplantation	28
1617. Assessment of Bloodstream Infections in Patients with Intrapartum Fever	27
2298. Clinical and Demographic Characteristics of COVID-19 in Pediatric Patients in the United States	27
2810. A synergy test to assess the activity of the Ceftazidime-Avibactam and Aztreonam combination: An experience from a single centre in Malaysia	27
580. Influenza, SARS-CoV-2, and routine childhood vaccines – trends in vaccine hesitancy in hospitalized children before and during the COVID-19 pandemic	27
LB1530. Clinical Benefit of Oral sabizabulin for Hospitalized Adults with CoVID-19 on Supplemental Oxygen	27
1322. Infectious Complications Following Pediatric Lawn Mower Injury: A Case Series	27
1842. Intravenous to Oral Antibiotic Stepdown for Uncomplicated Streptococcal Bacteremia	27
236. Treatment of Recurrent Clostridioides difficile Infection With RBX2660 in Patients ≥ 65 Years Old With Underlying Comorbidities	26
1685. Antimicrobial Activity of Aztreonam-Avibactam Against Enterobacterales Causing Infection in United States Hospitals (2019-2021)	26
Immune-Based Therapy for Hospitalized Patients With COVID-19 and Risk of Secondary Infections: A Systematic Review and Meta-analysis	26
1405. High risk or unstable substance use may predict OPAT nonadherence among people who use drugs (PWUD) admitted with invasive infections	26
1814. Retrospective Study of Skin and Soft Tissue Actinomycosis in an Urban Pediatric Academic Medical Center	26
168. Promising Changes In Antibiotic Utilization Associated With Implementation Of Rapid Multiplex Polymerase Chain Reaction Testing For Bloodstream Infection	26
1048. Biological Determinants of Post-Acute Sequelae of SARS-CoV-2	26
242. Evaluation of PBP4 promoter variation and clinical outcomes in patients with Enterococcus faecalis bacteremia	26
1812. Comparative Activity of Oritavancin and Comparator Agents against Staphylococcus aureus and Streptococcus spp. Causing Skin and Skin Structure Infections in US Medical Centers between 2017–2019	26
913. Incidentally Positive Measles Results with a Commercially Available Multiplex Polymerase Chain Reaction Panel for Exanthems — Tennessee, 2022–2023	25
155. Use of MRSA PCR and Antimicrobial Stewardship Intervention to Limit Anti-MRSA Therapy in Respiratory Tract Infections at a Community Teaching Hospital	25
534. Healthcare Resource Utilization and Costs among Patients with COVID-19 in the United States	25
120. Safety, Reactogenicity, and Immunogenicity of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-In-Human, Phase 1/2a Stud	25
447. Clinical Features, Risk Factors, and Outcomes of COVID-19 in Immunocompromised Adults Hospitalized with Acute Respiratory Infection	25
738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia	25
751. Decoding a Decade: Temporal Trends of MIC Distribution of Antifungals Against Cryptococcus species From a Reference Laboratory	25
549. Ensitrelvir for the Treatment of COVID-19 Infection: Evaluation of Taste Disorder and Smell Disorder in the Phase 3 Part of the Phase 2/3 SCORPIO-SR Randomized Controlled Trial	25
Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial	25
91. Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization	25
1548. Evaluation of rural HIV screening in adults with one or more risk factors	25
2717. Beware the bacteria: risk of bacterial infections persists more than 60 days post CAR-T	25
603. Comparing assays for Clinical Phage Microbiology in biofilm	25
382. A Hot Topic: the Relationship Between Climate Variability and Vector Specific Trends in Tick-Borne Diseases in New Jersey	24
2379. An Urban Detroit Clinic’s Experience in Bivalent COVID-19 Booster Uptake in People Living with HIV	24
1353. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of COVID-19: Final Analysis of the STORM CHASER Phase 3 Study	24
P-1011. Real-World Antifungal Therapy Patterns in US Patients with Invasive Aspergillosis: It’s Complicated	24
121. Safety, Tolerability, and Pertussis Immunogenicity Findings From a Randomized, Participant-Blinded, Active-Controlled, Dose-Escalating, Phase 1 Trial of a Tetanus/Diphtheria/Pertussis Booster Vac	24
639. Vaccination in Kidney Transplant Candidates	24
1228. Evaluation of the Practice of Switching from Intravenous to Oral Antimicrobial Therapy at King Abdulaziz University Hospital	24
1801. LVAD antimicrobial prophylaxis and infections, a 12-year experience	24
157. Implementation of multidisciplinary diagnostic stewardship for Clostridioides difficile infection during the COVID-19 pandemic at a small Japanese hospital	23
P-2355. Etiology and symptoms of respiratory tract infections among nursing home residents: Results from multiplex respiratory pathogen testing in the Nursing Home Public Health Response Network, Febr	23
P-970. Impressions of the Pediatric Infectious Diseases Subspecialty by Pediatric Resident Physicians and Medical Students Following a Peds ID Elective Rotation	23
228. Increased Incidence of Invasive Haemophilus influenzae Infections in Adults in Central Massachusetts	23
972. Bone and Joint Infections : Looking Beyond Gram Positive Bugs, A Case Series from Mumbai, India	23
537. First Week Post-Operative C-Reactive Protein Kinetics Show Different Patterns of Association with Infection Depending on the Type of Surgery	23
266. Cumulative Steroid Dose in Hospitalized Patients and COVID-19 Associated Pulmonary Aspergillosis	23
P-125. A Single-Center Descriptive Analysis of Cryptosporidiosis in Immunocompromised Patients	23
P-1595. Short Interval Repeat Testing with a Multiplex Pneumonia Panel is Low Yield- A Case for Diagnostic Stewardship	23
P-1776. Impact of Sepsis Recognition Tools and Pharmacy Workflow on Sepsis Management and Outcomes	23
2695. Lung Transplant Recipients With High Risk Cytomegalovirus Mismatch Donors Managed Using A Multimodality Regimen: A Five-Year Study	23
564. Nocardiosis in Portugal: a single-center experience	23
1110. Why has Utilization of Novel Gram-negative Antibiotics been Sluggish in U.S. Hospitals? A Retrospective Cohort Study to Inform Future Antibiotic Development and Market Entry Rewards	23
1084. Comparison of Pediatric SARS-CoV-2 Infections During Spring 2020 and Spring 2021	23
405. Utilization of a novel humble inquiry interview approach in assessing implementation barriers to a Nurse Driven Clostridioides difficile infection (CDI) order set	22
P-1873. Telavancin Outcomes in Infections Treated with Outpatient Parenteral Antibiotic Therapy (OPAT)	22
2160. Emergence of INDEL Mutations in KPC-2: Insights into Ceftazidime-Avibactam and Imipenem-Relebactam Efficacy	22
Viewpoint on Human Immunodeficiency Virus Medical Care Retention Guidelines in the Coronavirus 2019 Pandemic Era and Beyond: Lessons Learned From Electronic Health Record Screening and Outreach	22
1257. Antiretroviral treatment failure in a prospective cohort of Persons Living with HIV in the Philippines	22
P-1039. Plasma Cathelicidin (LL37) Levels Are not Associated with Candida Gut Colonization in Critically Ill Patients	22
P-1679. Discrepancies in antibiotic prescribing: revealing inappropriate use patterns	22
P-1754. An Antimicrobial Stewardship Program (ASP) Without Antibiotic Restrictions - Performance Update	22
P-1976. Incidence and Outcomes of Community-Onset Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections in the Pre- and Post-COVID-19 Pandemic	22
P-1139. Surveying Antibiotic Treatment for Pediatric Patients with Suspected Urinary Tract Infections at Madigan Army Medical Center	22
2175. Emergence of Dual-Carbapenemase Producing Enterobacterales in Chile After the COVID-19 Pandemic	22
P-1003. Group B Streptococcus Colonization in Pregnant Women and Their Infants: Prevalence of Colonization, Vertical Transmission, and Serotype Dynamics	22
1087. COVID-19 in Solid Organ Transplant Recipients: A Single Transplant Center Experience	22
Evaluation of the Tuberculosis Infection Care Cascade Among Pregnant Individuals in a Low-Tuberculosis-Burden Setting	22
620. Pharmacokinetic-Pharmacodynamic Analysis of Oral Vancomycin and Gut Microbiome Changes in Healthy Volunteers: an Exploratory Study	22
P-890. Risk Factors Associated with Carbapenem-Resistant Enterobacteria Bacteremia and Mortality in Patients with Acute Leukemia	22
1034. Risk Score for the Need of Mechanical Ventilation in Adults Presenting with Encephalitis.	21
P-1424. Patient Experiences at Month 6 after Initiation of Cabotegravir Long-Acting (CAB LA) for PrEP in the First Male Gender Concordant Implementation Science Trial (PILLAR) in the US	21
444. Effect of multidisciplinary management of CKD on proteinuria in people with HIV	21
601. Characterizing Modifiable Risk Factors for Liposomal Amphotericin B (L-AMB) Nephrotoxicity	21
2844. Impact of Altered Mental Status on Antibiotic Prescribing in Patients with Pyuria	21
2903. Early Experience With Omadacycline For The Treatment Of Diabetic Foot Infections	21
1005. Financial and clinical impact of ceftolozane/tazobactam global recall on the treatment of multi-drug resistant Pseudomonas in a large health system	21
1301. ID Fellows Cup: Developing Confidence Through Content Creation	21
P-1340. Genetic Factors Associated with Cefepime and Piperacillin/Tazobactam Resistance in Clinical Extended-Spectrum Beta-Lactamase-Producing Enterobacterales from the Intensive Care Unit	21

984. Detection of Mycobacterial Species from Specimens Submitted for Metagenomic Analysis	21
386. Participant Reflections on Their Experiences Participating in Phase 1 and 2 Inpatient Vaccine Trials and Human Challenge Studies	21
1130. Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure – Results from the placebo-control	21
2890. Pharmacokinetics, Safety, and Efficacy of Ceftazidime-Avibactam in Neonates and Young Infants with Bacterial Infections: Results from a Phase 2a, 2-part, Open-label, Non-randomized, Multicenter	21
Reactivation of Multidrug-Resistant HSV-1 in a Post–Allogenic Hematopoietic Stem Cell Transplant Patient: Dynamic Detection of the Rare A605V Mutation by Next-Generation Sequencing	21
166. Impact of Pneumonia Panel Implementation with Stewardship Support on Antibiotic De-escalation in the ICU	21
2253. Hospitalist Antibiotic Prescribing Patterns by Hour and Weekday	21
124. Activity of Novel b-Lactam/b-Lactamase Inhibitor (BL/BLI) Combinations Against AmpC-Producing Species Collected in United States Hospitals	21
882. Gender Disparities in Faculty Rank and Mentorship opportunities Within a Sample of US Academic Infectious Disease Divisions	21
2843. Risk Factors for Unplanned Healthcare Encounters in Patients Discharged from the Emergency Department with Extended-spectrum β-lactamase Urinary Tract Infections	21
P-971. Chogoria Rounds: A Novel Clinical Reasoning Tool for Residents	20
Correction to: Diagnostic Dilemmas: A Review of Reported Cases of Human Herpesvirus 6 Encephalitis in Immunocompetent Adults	20
P-71. Combined Orthopaedic and Infectious Disease Periprosthetic Joint Infection Clinic: A Survey Study	20
P-1063. SCY-247: A Second-generation IV/Oral Triterpenoid Antifungal with Extensive Tissue Distribution and Pharmacokinetics, and Low Drug-Drug Interaction Potential	20
P-1617. Clinical and microbiologic outcomes associated with implementation of MALDI-TOF on patients with anerobic, fungal, and non-lactose fermenting specimens	20
P-463. Diversity of KSHV Subtypes in People Living with HIV in a Large Urban Center in Dallas, Texas	20
1298. High Prescription Rate of Medications with Significant Rifampin Drug Interactions in Patients with Diabetic Foot Osteomyelitis: Should Rifabutin be Included in Clinical Trials for Adjunctive The	20
P-1386. Developing a Diagnostic Strategy for the Diagnosis of Bacterial Vaginosis: A Shift from Subjective to Objective Approach	20
Reply to Heldman et al	20
216. Effectiveness of JYNNEOS Vaccination in Preventing Lesion Dissemination Among Individuals with Confirmed Mpox Infection	20
P-1052. Identifying Facility and Specimen Type Associated with Screening-to-Clinical Candida auris Patients in the United States, 2013–2022	20
P-177. Contemporary Clinical Characteristics and Outcomes of Leprosy— a Multicenter Network Analysis	20
407. Prevalence of Post-COVID Sequelae Amongst Fully Vaccinated and Unvaccinated US Hospitalized Veterans	20
P-1123. Characterization of microbiological isolates in the newborn unit of the San Ignacio university hospital between 2018 and 2022	20
Adenovirus Infections and Disease in Solid Organ Transplant Recipients: Incidence and Outcomes	20
311. Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) P	20
P-450. Burden of Fungal Infection among People Living with HIV (PLHIV): A Nationwide Inpatient Data Analysis (2019-2021)	20
513. Evaluating the safety of baricitinib versus tocilizumab in hospitalized patients with COVID-19	20
1970. SARS-CoV-2 T-cell specific responses in allogeneic hematopoietic stem cell transplant recipients after second and third dose of BNT162b2 mRNA vaccine	19
P-2354. Neonatal Enterovirus and Parechovirus Infections—National Enterovirus Surveillance System, United States, 2004–2022	19
P-380. Risk Factors and Clinical Outcomes of Breast Surgery Related Surgical Site Infections in Southeast Michigan	19
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppressio	19
P-763. Assessment of the in vitro potency of anti-mycobacterial agents against clinical Mycobacterium avium complex (MAC) pulmonary isolates: implications of intravenous and inhaled amik	19
P-693. RSV Pneumonia Incidence in Solid Organ Transplant Recipients from 2014 to 2023 in an US Collaborative Network	19
874. Rapid Prediction of Antibiotic Susceptibility in Blood Stream Infections Using Direct Sequencing from Blood Cultures Coupled with Neighbour-Typing Prediction Algorithms.	19
P-2213. Lung Microbiome Diversity Associated with Hospital Mortality in Intubated Patients Admitted to the ICU	19
Prevalence of Naturally Occurring HIV-1 Capsid Inhibitor Resistance–Related Mutations in Antiretroviral Therapy–Naïve and –Experienced Individuals in Taiwan	19
375. Patient Safety Measures to Identify Excess Duration and Inappropriately Broad Antimicrobial Use in Uncomplicated Community-Acquired Pneumonia	19
2943. Hazardous Alcohol Use and Direct-acting Antiviral Therapy Initiation Among People Who Inject Drugs with Current Hepatitis C Infection	19
869. Evaluation of the Impact of Polymicrobial Bloodstream Infections (BSIs) on the Performance of BioFire Blood Culture Identification 2 (BCID2) Multiplex Polymerase Chain Reaction (PCR) Panel	19
Correction to: International Survey Reveals Opportunities to Improve Tuberculous Meningitis Management and the Need for Standardized Guidelines	19
P-2170. CMV T-cell Immunity Panel (TCIP)-Guided Secondary CMV Prophylaxis Duration in Lung Transplant Recipients	19
P-2226. Clinical Validation and Performance of Molecular Syphilis Diagnosis by Loop-Mediated Isothermal Amplification	19
1023. Suppressed Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide vs. Dolutegravir/Lamivudine: Virologic Failure and Durability	19
2277. Variability in Changes in Physician Outpatient Antibiotic Prescribing from 2019 to 2021 during the COVID-19 Pandemic in Ontario, Canada	19
P-800. High prevalence of treatment initiation delays among people diagnosed with multidrug-resistant tuberculosis-Dushanbe, Tajikistan—2019-2021	19
567. Performance of IgM and IgG antibodies against Bartonella henselae for diagnosis of Cat Scratch Disease in pediatric patients	19
2419. Increasing Misattribution of Bacteremia as CLABSIs by NHSN Definitions: A Tertiary Care Center Perspective	18
P-2103. Implementation of an Infectious Disease eConsult Service at an Urban Academic Medical Center	18
P-1254. Evaluation of Ceftriaxone Population Pharmacokinetics (PK) and Pharmacodynamics (PD) in Critically Ill Pediatric Population	18
Exploring Natural Immune Responses to Shigella Exposure Using Multiplex Bead Assays on Dried Blood Spots in High-Burden Countries: Protocol From a Multisite Diarrhea Surveillance Study	18
High Seroprevalence of Kaposi Sarcoma–Associated Herpesvirus in Men Who Have Sex With Men With HIV in the Southern United States	18
Propensity-Matched Comparison of Timely vs Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia	18
P-1969. Safety, Immunogenicity, and Pharmacokinetics of Repeat Dosing with AZD7442 (Tixagevimab/Cilgavimab): Final Analysis of the ENDURE Phase 2, Dose-Ranging Study in Immunocompromised Participants	18
P-1349. Multi-hospital Dissemination of Ampicillin Resistance Associated with a Frame-shift Deletion in pbp4 of Vancomycin-Resistant Enterococcus faecalis (VREfs)	18
A Family at War—Against Tropheryma whipplei : A Case Series	18
Transitioning to Shorter, Oral Antimicrobial Therapy for Pelvic Osteomyelitis in Patients Living With Spinal Cord Injury	18
Intermittent Versus Daily Trimethoprim/Sulfamethoxazole Regimens for Pneumocystis Pneumonia Prophylaxis: A Systematic Review and Meta-analysis	18
Profiles of HBcrAg and pgRNA in Pregnant Women With Chronic HBV Under Different Disease Phases and Antiviral Prophylaxis	18
P-610. HPV vaccine knowledge, attitudes and practices among healthcare providers before introduction to the national schedule, Almaty, Kazakhstan - 2023	18
Quantifying Antimicrobial Disposals at Six Community Pharmacies With Longitudinal Medication Disposal Programs: An Underappreciated Component of a One Health Approach to Antimicrobial Stewardship	18
308. Injectable Scaffold-based Vaccination For Prevention of Periprosthetic Joint Infection	18
P-1756. Utility and Clinical Impact of Karius Testing in the Adult Population of a Tertiary Care Center: A Retrospective Study	18
Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection	18
Real-World Effectiveness of Intravenous and Oral Antibiotic Stepdown Strategies for Gram-Negative Complicated Urinary Tract Infection With Bacteremia	18
Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia	18
Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection	18
P-1488. Attitudes and decision making about older adult vaccination – results from a literature review to inform the design of a qualitative research study	17
P-431. Mycobacterium abscessus Infection in Children - A 7 Year Experience in a Tertiary Paediatric Centre in Singapore	17
P-1458. Awareness, Attitudes and Perceptions of Meningococcal Vaccines among Caregivers of Adolescents in the United States	17
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study	17
P-352. The Cyclical Cascade of HIV Care Engagement in Côte d'Ivoire	17
P-1882. Curriculum-Based Online Medical Education Effectively Improves Clinician Knowledge, Competence, Confidence, and Performance with Integrating Antimicrobial Stewardship When Diagnosing and Manag	17
P-1489. Evaluating the public health impact of infant RSV prophylaxis programs in Spain and the UK: results from the ongoing REACH study	17
P-1586. Safety and Efficacy of Vitamin D3 in the Management of COVID-19: A Systematic Review and Meta-Analysis	17
P-1575. Improving Transplant Infectious Diseases Revenue by Documentation, Coding and Billing Training	17
380. Implementing the Comparing Oral versus Parenteral Antimicrobial Therapy (COPAT) Clinical Trial to Influence Institutional Practice Transformation Towards Earlier Transition to Oral Antibiotics	17
P-1396. A Decade of Tuberculosis in Cancer Patients: Trends from Panama’s National Oncology Institute	17
P-1541. Process Development, Characterization, and Immunogenicity of Schistosoma haematobium Calpain-Based Vaccine Antigens	17
225. The Immunology and Safety of Maternal RSV Vaccination, Infant Nirsevimab Immunization, or Both Products- Interim Analysis of a Randomized Clinical Trial	17
P-1557. Characterization of Factor H Binding Protein Expression for Neisseria Meningitidis Serogroup B Isolates, 2015–2022	17
P-371. Few differences in persistence and virologic outcomes across age groups among CAB+RPV LA users: Findings from the OPERA Cohort	17
P-1138. Assessing Clinically Relevant Environmental Bacterial and Viral Contamination in Neonatal Care Areas	17
P-69. Clinical Characteristics, Antimicrobial Resistance Patterns, and Prognostic Factors of Corynebacterium spp. Bacteremia: A 15-Year Retrospective Study	17
P-1787. Clinically-Relevant Respiratory Pathogen Detection in Polymicrobial Samples by Targeted Next-Generation Sequencing	16
P-689. Racial and Ethnic Disparities in RSV Pneumonia: Propensity Score Matched Analysis from All of Us Cohort	16
P-863. Incidence and Cumulative Risk Factors for Prolonged QTc Interval in Cirrhotic Patients Receiving Fluoroquinolone Prophylaxis	16
P-535. Dengue Fever in Children at a General Hospital from Buenos Aires, Argentina, During 2023- 2024 Dengue Season	16
P-1651. Long-term Outcomes Compared between Children Hospitalized for Multisystem Inflammatory Syndrome in Children (MIS-C) and Children Hospitalized for Acute COVID-19, New Vaccine Surveillance Netwo	16
P-797. Novel Solution to Increase GI Screening in Patients with Streptococcus gallolyticus Bacteremia	16
P-381. Veterans on Cabotegravir-Rilpivirine Long Acting Treatment for HIV are Younger and More Urban Than Those Who Continue Oral ART	16
P-1083. Implementation of a Sustainable Process for Mupirocin Decolonization across Adult ICUs in an Urban Safety Net Hospital	16
P-2181. Post-Exposure Prophylaxis (PEP) of Respiratory Syncytial Virus (RSV) Infection After High-Inoculum RSV Human Challenge: Analysis of a Randomized Double-Blind, Placebo-Controlled Trial of EDP-3	16
P-557. A Cost-Effectiveness Analysis of Chikungunya Virus Vaccination in Brazilian Adults	16
203. The Path Toward Treatment: Identifying Barriers to Hepatitis C Care Linkage After Positive Emergency Department Screening	16